… the following main effects: center, coronary artery disease (CAD) presentation, diabetes, …
coronary artery bypass surgery (CABG), prior peripheral arterial disease, prior congestive heart …

… Conclusions: Our study shows that a significant proportion of stable CAD patients are treated
with clopidogrel as SAPT in modern practice. Several correlates of such an attitude were …

… revascularization procedure (percutaneous coronary intervention or coronary artery bypass
… cohort of contemporary patients with ACS, we observed that clopidogrel remains by far the …

… ) patients allowing us to focus specifically on ischemia-inducing stenoses. Finally, we also
discuss contemporary … for the management of patients with stable coronary artery disease. …

… -coronary artery bypass grafting (CABG)-related major bleeding when compared to clopidogrel.…
a more potent antiplatelet agent compared with clopidogrel.5 In addition to the increased …

… using newer agents were younger than the clopidogrel patients, with average ages of
56.3 years and 61.0 years, respectively (P < 0.001; see Appendix A for more detail). …

… with cardiovascular disease and is associated with an arteritis similar to Buergers disease,
nonatherosclerotic peripheral artery disease; … of background clopidogrel use highlighting the …

… cardiovascular morbidity and mortality. We sought to evaluate the risk of concomitant coronary
artery disease (CAD) in patients … ticagrelor was superior to clopidogrel in reducing that risk…

… analysis showed that clopidogrel had been and still was the most commonly used P2Y 12 …
as 2013 was still used in over 3/4 of patients in this database. The use of prasugrel appeared …

… of peripheral arterial disease, vascular death, or rehospitalization for acute ischemia compared
with placebo plus clopidogrel over 18 … Sharma et al., “Contemporary use of ticagrelor in …